Recurrent Campylobacter jejuni Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)-A Case Report.
Infect Dis Rep
; 14(1): 56-62, 2022 Jan 12.
Article
in English
| MEDLINE | ID: covidwho-1771175
ABSTRACT
There is limited evidence to guide successful treatment of recurrent Campylobacter infection in patients with common variable immunodeficiency (CVID) already managed on regular immunoglobulin therapy. The role of faecal microbiota transplant (FMT) is uncertain. We report a case of recurrent Campylobacter jejuni infection in a patient with CVID treated with repeated FMT with 18 months of symptom resolution prior to relapse.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
Language:
English
Journal:
Infect Dis Rep
Year:
2022
Document Type:
Article
Affiliation country:
Idr14010007
Similar
MEDLINE
...
LILACS
LIS